Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Nov;25(11):940–944. doi: 10.1136/jcp.25.11.940

Standardization of clinical enzyme assays: a reference method for aspartate and alanine transaminases.

J H Wilkinson, D N Baron, D W Moss, P G Walker
PMCID: PMC477570  PMID: 4648539

Full text

PDF
940

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BABSON A. L., SHAPIRO P. O., WILLIAMS P. A., PHILLIPS G. E. The use of a diazonium salt for the determination of glutamic-oxalacetic transaminase in serum. Clin Chim Acta. 1962 Mar;7:199–205. doi: 10.1016/0009-8981(62)90010-4. [DOI] [PubMed] [Google Scholar]
  2. BOYD J. W. The intracellular distribution, latency and electrophoretic mobility of L-glutamate-oxaloacetate transaminase from rat liver. Biochem J. 1961 Nov;81:434–441. doi: 10.1042/bj0810434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DALZIEL K. An inhibitor of liver alcohol dehydrogenase in preparations of reduced diphosphopyridine nucleotide. Nature. 1961 Sep 9;191:1098–1099. doi: 10.1038/1911098a0. [DOI] [PubMed] [Google Scholar]
  4. FAWCETT C. P., CIOTTI M. M., KAPLAN N. O. Inhibition of dehydrogenase reactions by a substance formed from reduced diphosphopyridine nucleotide. Biochim Biophys Acta. 1961 Nov 25;54:210–212. doi: 10.1016/0006-3002(61)90962-3. [DOI] [PubMed] [Google Scholar]
  5. HENLEY K. S., POLLARD H. M. A new method for the determination of glutamic oxalacetic and glutamic pyruvic transaminase in plasma. J Lab Clin Med. 1955 Nov;46(5):785–789. [PubMed] [Google Scholar]
  6. HENRY R. J., CHIAMORI N., GOLUB O. J., BERKMAN S. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol. 1960 Oct;34:381–398. doi: 10.1093/ajcp/34.4_ts.381. [DOI] [PubMed] [Google Scholar]
  7. KARMEN A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955 Jan;34(1):131–133. [PubMed] [Google Scholar]
  8. LAURSEN T., FROM HANSEN P. A fluorimetric method for measuring the activity in serum of the enzyme glutamic pyruvic transaminase. Scand J Clin Lab Invest. 1958;10(1):53–58. doi: 10.3109/00365515809079917. [DOI] [PubMed] [Google Scholar]
  9. Laudahn G., Hartmann E., Rosenfeld E. M., Weyer H., Muth H. W. Normalwerte der Serum-Transaminiasen bei Verwendung substratoptimierter Testansätze zur Aktivitätsmessung. Untersuchungsergebnisse bei 3979 klinisch gesunden Werktätigen beiderlei Geschlechts. Klin Wochenschr. 1970 Jul 15;48(14):838–847. doi: 10.1007/BF01583903. [DOI] [PubMed] [Google Scholar]
  10. Moss D. W., Baron D. N., Walker P. G., Wilkinson J. H. Standardization of clinical enzyme assays. J Clin Pathol. 1971 Nov;24(8):740–743. doi: 10.1136/jcp.24.8.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. REITMAN S., FRANKEL S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957 Jul;28(1):56–63. doi: 10.1093/ajcp/28.1.56. [DOI] [PubMed] [Google Scholar]
  12. ROSALKI S. B., WILKINSON J. H. A source of error in serum glutamicoxaloacetic transaminase determination. J Clin Pathol. 1959 Mar;12(2):138–139. doi: 10.1136/jcp.12.2.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rand R. N. Practical spectrophotometric standards. Clin Chem. 1969 Sep;15(9):839–863. [PubMed] [Google Scholar]
  14. SCHAFFERT R. R., KINGSLEY G. R., GETCHELL G. AUTOMATED DETERMINATION OF SERUM GLUTAMIC OXALACETIC AND GLUTAMIC PYRUVIC TRANSAMINASE. Clin Chem. 1964 Jun;10:519–532. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES